Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

ABVC BioPharma, Inc. - Common Stock (NQ: ABVC )

0.6550 -0.0330 (-4.80%)
Streaming Delayed Price Updated: 11:50 AM EDT, Mar 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 42,167
Open 0.6479
Bid (Size) 0.6550 (1)
Ask (Size) 0.6800 (1)
Prev. Close 0.6880
Today's Range 0.6403 - 0.6797
52wk Range 0.4000 - 1.730
Shares Outstanding 24,420,526
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
ABVC BioPharma Plans to Expand Investment in U.S. for Production Facilities and Products for Unmet Medical Needs
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Economy
Exposures Supply Chain
ABVC BioPharma Plans to Expand Investment in U.S. for Production Facilities and Products for Unmet Medical Needs
Over $100 Million Invested in the U.S. 
Via TheNewswire.com
Topics Economy
Exposures Supply Chain

Performance

YTD
+2.14%
+2.14%
1 Month
+55.58%
+55.58%
3 Month
+27.18%
+27.18%
6 Month
-5.10%
-5.10%
1 Year
-46.75%
-46.75%

More News

Read More
ABVC and BioLite Japan Implement Strategy to Advance Japan's Biotech Innovation Into Global Markets
Via NewMediaWire
Topics Artificial Intelligence
Exposures Artificial Intelligence
ABVC and BioLite Japan Implement Strategy to Advance Japan's Biotech Innovation Into Global Markets
Via TheNewswire.com
Topics Artificial Intelligence
Exposures Artificial Intelligence
AiBtl BioPharma Strengthens Partnership With ABVC BioPharma, Paying $150,000 in Licensing Fees
Via TheNewswire.com
ABVC Stock Earnings: ABVC BioPharma Reported Results for Q2 2024
Via InvestorPlace
Which stocks have an unusual volume on Monday?
Via Chartmill
On Friday, there are stocks with unusual volume. Let's take a look.
Via Chartmill
ABVC BioPharma Announces Potential $7M Cash Licensing Income from Existing Agreements in 2025
Via TheNewswire.com
ABVC BioPharma Announces Potential $7M Cash Licensing Income from Existing Agreements in 2025
Via NewMediaWire
Positive Market Response in Asia Fuels Potential Revenue Growth for ABVC and BioKey, Marching Into Global Dietary Supplements Market of USD 75.35 Billion
Via NewMediaWire
Topics Artificial Intelligence
Exposures Artificial Intelligence
Positive Market Response in Asia Fuels Potential Revenue Growth for ABVC and BioKey, Marching Into Global Dietary Supplements Market of USD 75.35 Billion
Via TheNewswire.com
Topics Artificial Intelligence
Exposures Artificial Intelligence
ABVC BioPharma and AiBtl BioPharma's Worldwide Business Development Team Participate in the 43rd Annual J.P. Morgan Healthcare Conference
Via NewMediaWire
ABVC BioPharma and AiBtl BioPharma's Worldwide Business Development Team Participate in the 43rd Annual J.P. Morgan Healthcare Conference
Via TheNewswire.com
ABVC BioPharma s ADHD and MDD Drug Polygala Tenuifolia a Natural Wonder With Potential of Transforming Mental Health Treatment of More Than 30 Billion Market
Via NewMediaWire
ABVC BioPharma s ADHD and MDD Drug Polygala Tenuifolia a Natural Wonder With Potential of Transforming Mental Health Treatment of More Than 30 Billion Market
Via TheNewswire.com
AiBtl BioPharma Strengthens Partnership With ABVC BioPharma, Paying $150,000 in Licensing Fees
Via NewMediaWire
ABVC BioPharma, Inc. Granted Additional 180-Day Grace Period to Regain Compliance With Nasdaq Bid Price Requirement
Via NewMediaWire
ABVC BioPharma, Inc. Granted Additional 180-Day Grace Period to Regain Compliance With Nasdaq Bid Price Requirement
Via TheNewswire.com
ABVC BioPharma and ForSeeCon: An Update on Alliance's Ophthalmology-Related Products
Via NewMediaWire
Topics Intellectual Property
Exposures Intellectual Property
ABVC BioPharma Secures an Additional Patent for ADHD Treatment, in Addition to the Granted U.S. and Australian Patents, Moving Forward to the Global Patent Map of $32.14 Billion Potential Market
Via NewMediaWire
Topics Intellectual Property
Exposures Intellectual Property
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
ABVC BioPharma, Inc. Reports Strong Q2 2024 Financial Results and Strategic Achievements
Via NewMediaWire
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.